Novartis Heart Failure Drug Cuts Death by 37 Percent: Study

Published November 10, 2012

Novartis heart failure drug cuts death by 37 percent: study

Filed under: drug treatment news 2012

LOS ANGELES | Tue Nov 6, 2012 8:54pm EST. LOS ANGELES (Reuters) – An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a …
Read more on Reuters

Novartis Drug Works to Treat Rare Cushing's Disease

Filed under: drug treatment news 2012

Novartis AG (NOVN)'s treatment for Cushing's disease helped some patients, potentially providing a second marketed therapy for the rare condition, U.S. regulators said. The drug known as pasireotide decreases levels of the hormone cortisol, which in …
Read more on Bloomberg